Main Article Content

Afif Rakha Murtadha
Tri Murti Andayani
Dwi Endarti

Page: 2473-2486

Abstract

Background: Hypertension is a chronic condition significantly impacting physical and psychological well-being. HRQoL instruments must undergo cross-cultural adaptation and psychometric evaluation before clinical application. Objective: This systematic review evaluated the psychometric robustness (reliability, validity, responsiveness) of hypertension-specific HRQoL instruments. Methods: Eight databases were searched for original research published in English or Indonesian (2021–2026) following PRISMA 2020. Methodological quality and evidence certainty were assessed using COSMIN and modified GRADE. Results: 13 studies from 10 countries were included. Six instruments (46.1%) demonstrated strong psychometric profiles, including adequate content validity and robust reliability. While content validity (100%) and internal consistency (84.6%) were strong due to rigorous adaptation, divergent validity and responsiveness were severely underreported (84.6%). According to COSMIN guidelines, test-retest reliability studies with sample sizes below 50 participants are considered to have 'Low' GRADE evidence quality due to insufficient precision, despite demonstrating adequate ICC values. QLICD-HY, STI-HRQoL, and DASI provided the strongest evidence. Conclusion: Instruments are generally reliable, yet future research must evaluate clinical responsiveness through longitudinal designs. Instruments with the strongest psychometric profiles, such as QLICD-HY and DASI, are recommended for accurate patient assessment.

Downloads

Download data is not yet available.

Article Details

How to Cite
Murtadha, A. R., Andayani, T. M., & Endarti, D. (2026). Psychometric Properties of Quality of Life Instruments for Patients with Hypertension: A Systematic Review. Journal of Pharmaceutical and Sciences, 9(3), 2473–2486. https://doi.org/10.36490/journal-jps.com.v9i3.1724
Section
Review Article

References

Chantakeeree C, Sormunen M, Estola M, Jullamate P, Turunen H. Factors Affecting Quality of Life among Older Adults with Hypertension in Urban and Rural Areas in Thailand: A Cross-Sectional Study. Int J Aging Hum Dev 2022;95:222–44. https://doi.org/10.1177/00914150211050880.

Amlak BT, Getie A, Messelu MA, Ayenew T, GebreEyesus FA, Emire MS, et al. Health-related quality of life among adult hypertensive patients globally: a systematic review and meta-analysis. BMJ Public Heal 2025;3:e001662. https://doi.org/10.1136/bmjph-2024-001662.

Teoli D, Bhardwaj A. Quality of Life. National Institutes of Health.: StatPearls Publishing; 2023.

Lightfoot CJ, Howell M, Smith AC. How to assess quality of life in persons with chronic kidney disease. Curr Opin Nephrol Hypertens 2021;30:547–54. https://doi.org/10.1097/MNH.0000000000000740.

Schmidt M, Staemmler M. Comparison of instruments for measuring health-related quality of life and their applicability to ehealth applications. Stud Health Technol Inform 2021;283:202–8. https://doi.org/10.3233/SHTI210561.

van Krugten FCW, Feskens K, Busschbach JJV, Hakkaart-van Roijen L, Brouwer WBF. Instruments to assess quality of life in people with mental health problems: a systematic review and dimension analysis of generic, domain- and disease-specific instruments. Health Qual Life Outcomes 2021;19:1–13. https://doi.org/10.1186/s12955-021-01883-w.

Pequeno NPF, Pequeno NPF, Cabral NL de A, Marchioni DM, Lima SCVC, Lyra C de O. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes 2020;18:1–13. https://doi.org/10.1186/s12955-020-01347-7.

Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res 2018;27:1171–9. https://doi.org/10.1007/s11136-017-1765-4.

Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res 2021;30:647–73. https://doi.org/10.1007/s11136-020-02688-y.

Hernández-Segura N, Marcos-Delgado A, Pinto-Carral A, Fernández-Villa T, Molina AJ. Health-Related Quality of Life (HRQOL) Instruments and Mobility: A Systematic Review. Int J Environ Res Public Health 2022;19. https://doi.org/10.3390/ijerph192416493.

Mai VQ, Giang KB, Minh H Van, Lindholm L, Sun S, Sahlen KG. Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam. Qual Life Res 2022;31:539–50. https://doi.org/10.1007/s11136-021-02959-2.

Aueyingsak S, Khankaew K, Teerawattananant W, Singsangtam P, Sanmueang A, Yasud M, et al. Validity and reliability testing of the Thai version of the emPHasis-10 questionnaire for patients with pulmonary arterial hypertension. J Patient-Reported Outcomes 2026;10:1–8. https://doi.org/10.1186/s41687-026-01017-0.

Jiang J, Hong Y, Zhang T, Yang Z, Lin T, Liang Z, et al. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China. Qual Life Res 2021;30:2045–60. https://doi.org/10.1007/s11136-021-02786-5.

Jordan AN, Anning C, Wilkes L, Ball C, Pamphilon N, Clark CE, et al. Cross-cultural adaptation of the Spanish MINICHAL instrument into English for use in the United Kingdom. Health Qual Life Outcomes 2022;20:1–12. https://doi.org/10.1186/s12955-022-01943-9.

Mustafaoglu R, Demir R, Aslan GK, Sinan UY, Zeren M, Yildiz A, et al. Translation, cross-cultural adaptation, reliability, and validity of the Turkish version of the Duke Activity Status Index in patients with pulmonary hypertension. Pulmonology 2021;29:S18–24. https://doi.org/10.1016/j.pulmoe.2021.06.008.

Shi Y, Dong X, Hu X, Weng L, Liu Y, Lai J, et al. Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification. BMC Pulm Med 2022;22:1–7. https://doi.org/10.1186/s12890-022-02056-1.

Febriana A, Pelfbrianti D, Ifansyah MN, Lestari DH. Validitas dan Reliabilitas Instrumen Kualitas Hidup Lansia dengan Hipertensi. Indones J Heal Promot 2023;6:1401–6.

Dave Y, Sorani D, Patel M. Cross Cultural Adaptation, Translation, Validation and Reliability Analysis of Gujarati Version of Hypertension Quality of Life Questionnaire (MINICHAL). Int J Heal Sci Res 2021;11:10–6. https://doi.org/10.52403/ijhsr.20211003.

Nikolic A, Biocanin V, Rancic N, Duspara M, Djuric D. Serbian Translation and Validation of the SF-36 for the Assessment of Quality of Life in Patients with Diagnosed Arterial Hypertension. Exp Appl Biomed Res 2023;24:227–34. https://doi.org/10.2478/sjecr-2020-0073.

Liu X, Bai G, Li H, Li S. Applying SF ‑ 6D to measure health state utilities among the middle and old aged patients with hypertension in China. Health Qual Life Outcomes 2020;18:1–10. https://doi.org/10.1186/s12955-020-01598-4.

Miłek MW, Tkaczyk D, Torbicki A, Orłowska J, Kurzyna M, Wo´zniak-Prus M. Validation Analysis of the Polish-Translated Version of EmPHasis-10 Health-Related Quality of Life Questionnaire in Patients with Pulmonary Arterial Hypertension. J Clin Med 2026;15:1–12.

Rawlings GH, Gaskell C, Beail N, Thompson A, Armstrong I. Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension. Pulm Circ 2024;14:1–11. https://doi.org/10.1002/pul2.12378.

Jin KH, Sun SG. The Development of a Specific Quality of Life Scale for Hypertensive Patients: Methodological Study. Korean J Adult Nurs 2022;34:523–36. https://doi.org/10.7475/KJAN.2022.34.6.523.

Si Y, Guo L, Chen S, Zhang X, Dai X, Wang D, et al. Progressing towards the 2030 health-related SDGs in ASEAN: A systematic analysis. PLoS Med 2025;22:1–20. https://doi.org/10.1371/journal.pmed.1004551.

Smith L, Morris-Eyton H. Development, validation and reliability of the Smith Toolkit for Integrated Health Related Quality of Life (STI-HRQoL). Heal Sport Rehabil Med 2023;24:4–10. https://doi.org/10.26659/pm3.2023.24.1.4.

Liu Y, Chang Y, Wan D, Li W, Xu C, Wan C. Development and validation of a disease-specific quality of life measure QLICD-HY (V2.0) for patients with hypertension. Sci Rep 2023;13:1–12. https://doi.org/10.1038/s41598-023-39802-2.

Terwee CB, Elders PJM, Langendoen-Gort M, Elsman EBM, Prinsen CAC, van der Heijden AA, et al. Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review. Curr Diab Rep 2022;22:405–21. https://doi.org/10.1007/s11892-022-01482-z.

Li X, Li R, Li M, Hui X, Li J, Yao L, et al. A Systematic Review and Quality Assessment of Cardiovascular Disease–Specific Health-Related Quality-of-Life Instruments: Part II Psychometric Properties. Value Heal 2025;28:294–305. https://doi.org/10.1016/j.jval.2024.08.011.